BioSante Pharmaceuticals Reports Product Development Highlights and Third Quarter 2005 Financial Results.
Business Wire › November 10, 2005
Linked as:
Extract
BioSante Pharmaceuticals Reports Product Development Highlights and Third Quarter 2005 Financial Results.
LINCOLNSHIRE, Ill. -- BioSante Pharmaceuticals, Inc. (AMEX:BPA) today reported product development highlights and financial results for the third quarter ended September 30, 2005.
"We achieved milestones across our key clinical programs this quarter. We presented positive Phase III data for Bio-E-Gel(TM), licensed three p...See the full content of this document
Sponsored links
